JZP-430 |
Katalog-Nr.GC34640 |
JZP-430 ist ein potenter, hochselektiver, irreversibler Inhibitor der α/β-Hydrolase-DomÄne 6 (ABHD6) mit einem IC50 von 44 nM, weist eine ~230-fache SelektivitÄt gegenÜber FettsÄureamidhydrolase (FAAH) und lysosomaler SÄurelipase (LAL) auf ).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1672691-74-5
Sample solution is provided at 25 µL, 10mM.
JZP-430 is a potent, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) with an IC50 of 44 nM, exhibits ~230-fold selectivity over fatty acid amide hydrolase (FAAH) and lysosomal acid lipase (LAL)[1]. IC50: 44 nM (ABHD6, human)[1]
[1]. Patel JZ, et al. Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors. ChemMedChem. 2015 Feb;10(2):253-65.
Average Rating: 5
(Based on Reviews and 27 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *